Markets:

Overview

News

Currencies

International

Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

50.09 -0.71 (-1.40%)

Streaming Delayed Price Updated: 10:11 AM EST, Jan 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2 3 4 5 6 7 8 9

...

44 45 Next >

Sanofi Acquires Dynavax in $2.2 Billion Christmas Eve Deal, Sending Shares Soaring

December 24, 2025

In a blockbuster conclusion to the 2025 trading year, Dynavax Technologies (NASDAQ:DVAX) saw its stock price skyrocket by nearly 40% in premarket trading this morning, December 24, 2025. The surge...

Via MarketMinute

Topics Intellectual Property

Fitch Sees Stable 2026 Outlook For Global Pharma — But Warns Trump Drug Pricing Push Poses Profit Risk ↗

December 23, 2025

Via Stocktwits

Topics Government

The Pfizer Pivot: A Deep-Dive into PFE’s 2025 Financial Recovery and Strategic Rebirth

December 22, 2025

As of today, December 22, 2025, Pfizer Inc. (NYSE: PFE) stands as a case study in corporate reinvention and the brutal reality of the post-pandemic "hangover." Once the darling of the global healthcare...

Via PredictStreet

Topics Economy Intellectual Property

ANAB Stock Falls After It Sues GSK Unit Tesaro Again, Claims Fresh Breach Of 2014 Deal ↗

November 21, 2025

The dispute centers around Tesaro’s participation in PD-1 trials.

Via Stocktwits

Topics Lawsuit

Earnings Scheduled For October 29, 2025 ↗

October 29, 2025

Via Benzinga

GSK Buys Global Rights To Preclinical Cancer Therapy For $357M ↗

October 27, 2025

Via Stocktwits

Moderna (MRNA): The “Act 2” of an mRNA Pioneer – A 2025 Deep Dive

December 22, 2025

As of December 22, 2025, Moderna, Inc. (NASDAQ: MRNA) stands at a critical juncture in its corporate evolution. Once the poster child for the biotechnology industry’s rapid response to the global...

Via PredictStreet

Topics Earnings Initial Public Offering Intellectual Property

GSK PLC-SPON ADR (NYSE:GSK) Shows Strong Technical Setup for Potential Breakout ↗

December 20, 2025

GSK stock shows strong technical strength and a high-quality setup, signaling a potential breakout for trend-focused investors.

Via Chartmill

Trump Strikes New Drug-Price Deals With Roche, Novartis, Merck And Other Pharma Giants ↗

December 19, 2025

The deals expand the pricing program to most targeted drugmakers in exchange for temporary tariff relief.

Via Stocktwits

Topics Government World Trade

Exdensur (depemokimab) approved by US FDA for the treatment of severe asthma

December 16, 2025

From GSK plc

Via Business Wire

Great Rotation: Tech Exodus Fuels Dow's Record Run While Nasdaq Struggles

December 12, 2025

As of December 12, 2025, the financial markets are witnessing a significant "Great Rotation," a pronounced shift of capital from high-growth technology and Artificial Intelligence (AI) stocks to more...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Value Stocks Stage a Comeback Bid Amidst Persistent Growth Dominance

December 11, 2025

The financial markets in late 2025 present a complex narrative, a tug-of-war between the long-reigning titans of growth and a resurgent, yet often overshadowed, cohort of value stocks. While the...

Via MarketMinute

Topics Artificial Intelligence ETFs Economy

GSK PLC-SPON ADR (NYSE:GSK) Presents a High-Probability Technical Breakout Setup ↗

November 29, 2025

GSK stock shows strong technical momentum and a high-quality consolidation pattern, indicating a potential breakout opportunity for traders.

Via Chartmill

Biotech Bull ETF Surges To 20-Month High: Analysts Say Medicare’s Drug-Pricing Blow Is Softer Than Feared ↗

November 27, 2025

Pricing updates for major therapies from Novo Nordisk, Teva, AbbVie, and others eased sector worries.

Via Stocktwits

Topics ETFs

JPMorgan Says 2027 Medicare Drug Prices Signal Up To 40% Cuts Ahead — Novo Nordisk And Teva Stand Out As Top Targets ↗

November 26, 2025

JPMorgan said the implied net impact aligns with recent commentary from Novo Nordisk, Teva and AbbVie during earnings season.

Via Stocktwits

Topics Economy Government

The Best Healthcare Stock to Hold in Uncertain Times ↗

November 14, 2025

Looking for a cheap, safe healthcare stock to buy? Take two shares of GSK and call me in the morning.

Via The Motley Fool

Topics Economy World Trade

AI’s Next Frontier: Key Stocks to Watch Amidst Market Shifts and Technological Leaps

November 10, 2025

The artificial intelligence (AI) sector is currently navigating a period of unprecedented dynamism, characterized by explosive technological advancements, massive capital inflows, and a palpable...

Via TokenRing AI

Topics Artificial Intelligence

AnaptysBio To Save $10 Million After Discontinuing Ulcerative Colitis Study ↗

November 10, 2025

AnaptysBio ends its ulcerative colitis trial after rosnilimab misses key goals, focusing resources on rheumatoid arthritis and future programs.

Via Benzinga

Looking Into GSK PLC's Recent Short Interest ↗

November 07, 2025

Via Benzinga

FDA Fast-Tracks 6 More Drugs - Obesity And Cancer Drugs Included ↗

November 07, 2025

FDA adds six drugs to its priority voucher program as CMS and the White House unveil measures to speed reviews and lower prescription costs.

Via Benzinga

AI Revolutionizes Pharma Supply Chains: A New Era of Localized Resilience and Efficiency

October 31, 2025

The pharmaceutical industry is experiencing a profound and immediate transformation as Artificial Intelligence (AI) becomes a strategic imperative for localizing supply chains, fundamentally enhancing...

Via TokenRing AI

Topics Artificial Intelligence Economy Fraud

The Fading Luster: Is the "Gold Rush Over" While Stocks Remain "Overheated"?

November 05, 2025

The financial markets are currently grappling with a potent and increasingly vocal narrative: the "gold rush is over" for commodities, particularly gold, while the stock market, especially in certain...

Via MarketMinute

Topics Artificial Intelligence Cannabis ETFs

2 High-Yield Stocks With Fresh Catalysts ↗

October 29, 2025

Income investors can capture yields above 5% from companies executing business transformations.

Via The Motley Fool

Topics Lawsuit

Navigating the Turbulence: Understanding Market Volatility Amidst Record Highs

October 29, 2025

As late 2025 unfolds, the global stock market presents a fascinating paradox: major U.S. indices, including the S&P 500, Dow Jones Industrial Average (NYSE: ^DJI), and Nasdaq Composite (NASDAQ: ^IXIC),...

Via MarketMinute

Topics Artificial Intelligence Bankruptcy Bonds

GSK Upgrades 2025 Financial Outlook, CEO Says Positioned Well For 2026 ↗

October 29, 2025

GSK's Q3 sales and earnings topped estimates, driven by Specialty Medicines and vaccines, prompting the firm to raise its 2025 outlook.

Via Benzinga

GSK Jumps After Hiked 2025 Guidance Widely Outperforms Expectations ↗

October 29, 2025

GSK stock rose early Wednesday on strong 2025 guidance on the back of its third-quarter sales and earnings beat.

Via Investor's Business Daily

Dow Jones Soars to New Record High Amidst Wave of Optimism, Signaling Robust Market Confidence

October 27, 2025

The Dow Jones Industrial Average (DJIA) recently achieved a significant milestone, surging by over 200 points to close at an unprecedented all-time record high in October 2025. This remarkable ascent...

Via MarketMinute

Topics Artificial Intelligence Economy Energy

FDA Approves GSK's Withdrawn Blood Cancer Drug Blenrep ↗

October 24, 2025

FDA approves GSK's Blenrep combo for relapsed multiple myeloma, showing 51% reduced death risk and tripled progression-free survival in Phase 3 trial.

Via Benzinga

GSK Crumbles As Blood Cancer Comeback Falls Unexpectedly Short ↗

October 24, 2025

The company won approval for its drug, Blenrep. But it wasn't enough.

Via Investor's Business Daily

Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma

October 23, 2025

From GSK plc

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

44 45 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.